Regulating signaling pathways to restore immune homeostasis to fight cancer and autoimmune diseases
Regulating signaling pathways to restore immune homeostasis to fight cancer and autoimmune diseases
We have designed targeted, novel drugs to re-establish immune balance. Our groundbreaking strategies activate or down-modulate the immune system to fight cancer and autoimmune diseases.
We are first and foremost a target discovery platform, which has fueled our robust pipeline. Our portfolio includes first-in-class assets with the potential to target large indications with high unmet need. Our work has generated a broad pipeline of immunomodulators able to enhance or inhibit different signaling pathways.
.png)
.png)
We've assembled an experienced management team and world-renowned advisors with substantial expertise from small and large biopharma to generate an innovative pipeline for cancer and autoimmune diseases.
At Georgiamune, we've built a team of passionate and driven scientists, clinicians, and commercial experts to bring the full potential of immunotherapy to bear.
.svg.png){kind=logo}
.png)
.svg)